%0 Journal Article
%T Relation between the Severity of Obstructive Sleep Apnea and the Severity of Type 2 Diabetes Mellitus and Hypertension
%A Safwat A. M. Eldaboosy
%A Amgad Awad
%A Hussain Alquraini
%A Saber Abo Al Hassan
%A Mohamed O. Nour
%J Open Journal of Respiratory Diseases
%P 37-48
%@ 2163-9418
%D 2021
%I Scientific Research Publishing
%R 10.4236/ojrd.2021.112004
%X <b>Background:</b><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"> Obstructive sleep apnea
syndrome (OSAS) may promote</span></span></span></span><span><span><span><span style=\"font-family:;\" \"=\"\"><span style=\"font-family:Verdana;\"> hyperglycemia, insulin resistance, and hypertension
(HTN). </span><b><span style=\"font-family:Verdana;\">Purpose:</span></b><span style=\"font-family:Verdana;\"> To evaluate if there is a relationship between the
severity of OSA and the severity of type 2 diabetes mellitus (T2DM) and HTN in
our patients, aiming to understand and optimize the control for comorbidities. </span><b><span style=\"font-family:Verdana;\">Materials
and Methods:</span></b><span style=\"font-family:Verdana;\"> Patients referred for polysomnography (PSG) were
retrospectively recruited during the period from October 2017 to August 2020. A
STOP-BANG questionnaire formed eight questions was used to assess the risk of
OSAS. We divided the patients </span></span></span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">in</span></span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">to two group</span></span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">s</span></span></span></span><span><span><span><span style=\"font-family:;\" \"=\"\"><span style=\"font-family:Verdana;\">; group 1, who have snoring without T2DM, and group
2, who have snoring with T2DM. PSG was completed for all subjects and data were
collected for each patient including apnoea hypopnea index </span><span><span style=\"font-family:Verdana;\">(AHI), mean arterial oxygen saturation (SaO</span><sub><span style=\"font-family:Verdana;\">2</span></sub><span style=\"font-family:Verdana;\">),
and Nadir SaO</span><sub><span style=\"font-family:Verdana;\">2</span></sub><span style=\"font-family:Verdana;\"> recorded</span></span><span style=\"font-family:Verdana;\"> during PSG. Anthropometric data,
medical history, and medications for T2DM (for group 2) and HTN and HbA1c were
collected (for group 2). AHI was used to evaluate the severity of OSA and its
relation to T2DM and HTN. </span><b><span style=\"font-family:Verdana;\">Results:</span></b><span
%K Obstructive Sleep Apnea
%K Apnea-Hypopnea Index
%K Type 2 Diabetes Mellitus
%K Hypertension
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=108220